rs1284734503
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4
The NM_000171.4(GLRA1):c.1295T>C(p.Met432Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,613,770 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000171.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GLRA1 | NM_000171.4 | c.1295T>C | p.Met432Thr | missense_variant | Exon 9 of 9 | ENST00000274576.9 | NP_000162.2 | |
GLRA1 | NM_001146040.2 | c.1319T>C | p.Met440Thr | missense_variant | Exon 9 of 9 | NP_001139512.1 | ||
GLRA1 | NM_001292000.2 | c.1046T>C | p.Met349Thr | missense_variant | Exon 8 of 8 | NP_001278929.1 | ||
GLRA1 | XM_047417105.1 | c.1343T>C | p.Met448Thr | missense_variant | Exon 9 of 9 | XP_047273061.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GLRA1 | ENST00000274576.9 | c.1295T>C | p.Met432Thr | missense_variant | Exon 9 of 9 | 1 | NM_000171.4 | ENSP00000274576.5 | ||
GLRA1 | ENST00000455880.2 | c.1319T>C | p.Met440Thr | missense_variant | Exon 9 of 9 | 1 | ENSP00000411593.2 | |||
GLRA1 | ENST00000462581.6 | n.*1053T>C | non_coding_transcript_exon_variant | Exon 8 of 8 | 1 | ENSP00000430595.1 | ||||
GLRA1 | ENST00000462581.6 | n.*1053T>C | 3_prime_UTR_variant | Exon 8 of 8 | 1 | ENSP00000430595.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152134Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251298Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135806
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461636Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727136
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152134Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74300
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: GLRA1 c.1295T>C (p.Met432Thr) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251298 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.1295T>C in individuals affected with Hyperekplexia 1 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 532839). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Hyperekplexia 1 Uncertain:1
- -
Inborn genetic diseases Uncertain:1
The c.1295T>C (p.M432T) alteration is located in exon 9 (coding exon 9) of the GLRA1 gene. This alteration results from a T to C substitution at nucleotide position 1295, causing the methionine (M) at amino acid position 432 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Hereditary hyperekplexia Uncertain:1
This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 432 of the GLRA1 protein (p.Met432Thr). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with GLRA1-related conditions. ClinVar contains an entry for this variant (Variation ID: 532839). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt GLRA1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at